Psoriasis

• EMA label_change · 2026-03-23
  EMA Authorised: Tremfya — Janssen-Cilag International NV

  EU authorises Tremfya to treat psoriasis, Crohn's disease, and ulcerative colitis.

• FDA label_change · 2026-03-16
  FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)

  FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical …

• FDA label_change · 2025-06-27
  FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)

  FDA approves a supplemental application for Ustekinumab (Stelara) by Janssen Biotech, resulting in updated labeling.

• FDA label_change · 2023-07-17
  FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Viona Pharmaceuticals Inc)

  The FDA approved a supplemental application for Betamethasone Dipropionate from Viona Pharmaceuticals Inc, typically reflecting labeling cha…

• FDA label_change · 2023-05-10
  FDA Approved: METHYLPREDNISOLONE ACETATE — Supplemental Application (Sandoz Inc.)

  FDA approved a supplemental application for methylprednisolone acetate by Sandoz Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2015-05-21
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories to update the product labeling.

• FDA label_change · 2012-12-07
  FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc., updating the product labeling. This…

• FDA label_change · 2011-01-12
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  FDA approved a supplemental labeling change for Clobex (clobetasol propionate) by Galderma Laboratories.

• FDA label_change · 2007-12-12
  FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)

  FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…